Ladies and gentlemen, we're now back in session. I'm going to introduce the witnesses at the table.
We have, from Doctors Without Borders, Emilou MacLean, who is director of the United States of America Campaign for Access to Essential Medicines. We have Grant Perry from GlaxoSmithKline Canada, vice-president of public affairs and reimbursement. We have, from the National Advocacy Committee of the Grandmothers to Grandmothers Campaign, Elizabeth Rennie and Linda Watson. From Apotex Inc., we have Bruce Clark, vice-president of regulatory and medical affairs. From Canada's Research-Based Pharmaceutical Companies, we have Russell Williams, president, and we have Laurence Dotto, director, government and external affairs.
Then we have, by teleconference, Angus Livingstone, managing director, University-Industry Liaison Office, University of British Columbia.
Who is going to make the opening remarks for the Grandmothers to Grandmothers Campaign?
Okay, if you would, please begin now, Ms. Rennie, for five minutes.